



In the past few decades, there has been increasing concern towards the potential 
effects of industrial pollutants on our eco-system. Each country has developed and 
enacted stringent environmental regulatory standards to address this concern. Several 
studies conducted in the general area of regulatory impact show significant direct 
impact of these regulations on organizations which includes product redesign; process 
redesign; use of environment friendly raw material; incorporating systems and 
mechanisms for life cycle management, waste management systems, recycling and 
reuse; and developing structures and mechanisms to monitor compliance. 
Pharmaceutical industry in particular, due to the generation of variety of hazardous 
waste during manufacturing, maintenance and housekeeping operations, is one among 
the highly regulated industrial sector globally. Following these stringent regulatory 
standards is a major concern for the Pharmaceutical Small and Medium Enterprises 
(PSMEs).The financial and human liabilities and resource shortages associated while 
incorporating abatement technologies and related procedural changes make them 
highly vulnerable to these compliance standards.  
 
This study aims to investigate two aspects of environment regulation compliance in 
the PSMEs, namely,  
• to identify the nature and magnitude of vulnerabilities encountered by 
Pharmaceutical Small and Medium Enterprises (PSMEs) in India while 
complying with environmental regulations, and  
• to explore the adaptation mechanisms followed by the Pharmaceutical Small 
and Medium Enterprises (PSMEs) in India, in complying with environmental 
regulations. 
 
Literature explorations in the area of environmental regulation, enforcement, 
compliance, pharmaceutical industry and SMEs, gave limited studies with focus on 
India. However, studies with focus on economically developed countries indicated 
some clear trends. One, PSMEs were seen to encounter significantly higher 
vulnerability in manufacturing and operations than in regulations, marketing, 
organizational policy or human resource, while complying with environment 
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regulations. Two, they were seen to feel significantly concerned about regulator and 
regulatory management. Three, the PSMEs had more external and management focus 
than technological and process change, in coping with environmental regulation 
compliance. Four, environmental compliance measures (nature of vulnerabilities and 
adaptation mechanisms) reflected significant differences among small and medium 
size pharmaceutical firms. Five, these environmental compliance measures had 
significant differences between different locations/regional clusters. 
 
These five trends formed our five hypotheses, to be investigated in the Indian 
scenario. A questionnaire based survey was administered online and face to face. The 
sampling design followed was stratified random and the total sample size taken for 
the final analysis was 71. The survey targeted the senior executive officers of 
pharmaceutical firms across India. Unstructured discussions and interactions with 
experts in the field were also carried out to understand the gravity of each concern.  
 
Data was analyzed using the Analytic Hierarchy Process (AHP) for exploring and 
prioritizing vulnerability concerns, factor analysis for identifying the general 
adaptation mechanisms and systems practiced, and cluster analysis for assessing the 
underlying relationship among vulnerability concerns and adaptation patterns of firms 
under study. 
 
Findings of the analysis highlighted several significant drivers of the interaction 
between the PSMEs and the environment regulations. Some of them are as follows: 
One, conforming to literature finding, our study also found manufacturing related 
problems as the most significant concern for the PSMEs. However, unlike the 
Western countries, it was the poor quality of raw material available in the market that 
was the main concern, and not the need for intensive capital investment in abatement 
technologies. Additionally, the Ayurvedic companies went against the general tide 
and highlighted organizational strategy as their most significant vulnerability. 
Investigations revealed the steady global market decline for this sub-sector and need 
for new innovations to meet the changing global needs. Two, marketing was a 
significantly higher concern for the PSMEs than regulator and regulatory 
management. Marketing has special relevance in the pharmaceutical industry as it 
deals with health and life saving issues for the people, and this got highlighted in our 
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results. Three, the study found external management factors as the most followed 
coping / adaptation mechanism pursued by the PSMEs. Conforming to literature 
findings, our study also demonstrated smaller firms as significantly more vulnerable 
to adaptation in comparison with medium scale firms.  
 
The study highlighted the attempt at balancing the local and global by the Indian 
PSMEs. While the process orientation was towards meeting international standards, 
the management of resources, marketing and regulatory requirements had a focus on 
the local pressures. The study provides some insight into the vulnerabilities and 
adaptation efforts of the Indian PSMEs and brings out the relevant strategic 
interventions from government, regulatory organizations and industry associations to 
develop a more sustainable business environment for the Indian PSMEs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
